阿昔洛韦与三氟胸腺嘧啶治疗基质性疱疹性角膜炎的对比研究
[Acyclovir versus trifluorothymidine in the therapy of stromal herpes keratitis].
作者信息
Behrens-Baumann W, Quentin C D, Vogel M
出版信息
Klin Monbl Augenheilkd. 1986 Oct;189(4):286-8. doi: 10.1055/s-2008-1050805.
PMID:3100859
Abstract
A randomized prospective double-blind trial with topical acyclovir (ACV) versus trifluorothymidine (TFT) was performed in the treatment of stromal keratitis. Resolution occurred in only one case (ACV). In all other cases the disease progressed, so that antiviral therapy was discontinued.
摘要
进行了一项随机前瞻性双盲试验，比较局部使用阿昔洛韦（ACV）与三氟胸腺嘧啶核苷（TFT）治疗基质性角膜炎的效果。仅1例（使用ACV）病情得到缓解。在所有其他病例中，病情进展，因此抗病毒治疗中断。
Zotero 插件